Fundraising FoxYsios Capital — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in
Co-investorsABS VenturesHatteras Venture PartnersNew Enterprise Associates (NEA)Treo Ventures, LlcWindham Capital PartnersAction Potential Venture Capital Ltd.+1 more
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)Miquel Vila-Perelló, Ph.D(Co-Founder & CEO)Silvia Frutos, Ph.D(Co-Founder & CTO)
Co-investorsAsabys PartnersNovartis Venture FundRoche Venture FundSanofi VenturesCriteria Bio VenturesNew Enterprise Associates (NEA)+3 more
LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.
AI & Machine LearningBiotechHealthtechMedical Devices
Ton AdanginHans van der Vliet(Head of Innovation)inSteve Hurly(Chief Executive Officer)Oxana Polyakova(Chief Scientific Officer)in
Co-investorsMRL Ventures FundSanofi VenturesGilde HealthcareNovo HoldingsREDMILE
Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.
AI & Machine LearningCloud ComputingDeveloper Tools
Jan Koehnlein(Founder)Johannes Landgraf(Founder)Moritz Eysholdt(Founder)Sven Efftinge(Founder)
Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesVertex VenturesAlta Life Sciences+7 more
Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.
BiotechHealthtechMedical Devices
Co-investorsAsabys PartnersFund+KorysMérieux Equity PartnersAlta Life SciencesBpifrance+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.